查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518263

2024 年無細胞 DNA (cfDNA) 測試全球市場報告

Cell Free DNA (cfDNA) Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

無細胞 DNA (cfDNA) 測試市場規模預計在未來幾年將呈指數級成長。 2028年，將以23.9%的複合年成長率成長至206.3億美元。預測期內的成長動力是向個人化醫療的轉變、醫療保健基礎設施的改善、人口老化和癌症發生率的上升。此外，精準醫學的日益普及、對液態切片技術的認知和接受度不斷提高，以及對 cfDNA 研究的投資和資金籌措的增加，也促進了這一成長。這段時期的主要趨勢包括液態切片技術的採用、下一代定序 (NGS) 技術的進步、人工智慧和機器學習在 cfDNA 測試中的整合、照護現場cfDNA 測試的發展以及資料的改進其中包括引入雲端基礎的平台。

癌症盛行率的不斷上升預計將推動未來無細胞 DNA (cfDNA) 檢測市場的成長。癌症包括一組複雜的疾病，其特徵是體內異常細胞的生長和擴散。這些細胞可以侵入並損害正常組織，如果不及時治療，會造成重大風險。癌症發生率的增加是由於人口老化、生活方式的改變、環境影響以及檢測和診斷方法的進步等因素造成的。 cfDNA 檢測可以在早期（通常在症狀出現之前）檢測到與癌症相關的基因突變。這種早期檢測可以及時干預，並透過在早期階段識別癌症來改善患者的治療結果和存活率。例如，2024 年 2 月，世界衛生組織 (WHO) 預測，到 2050 年，新增癌症病例數將超過 3,500 萬例，比 2022 年估計的 2,000 萬例增加 %。因此，癌症盛行率的增加正在推動無細胞 DNA (cfDNA) 檢測市場的成長。

無細胞 DNA (cfDNA) 測試市場的主要參與者正在優先開拓創新技術，例如液態切片測試，這些技術可以提高檢測與癌症相關的突變和基因變化的靈敏度、特異性和效率。液態切片測試是一種診斷程序，使腫瘤學家能夠評估癌細胞釋放的循環遊離 DNA，從而促進個人化的標靶治療策略。例如，2023年5月，美國生命科學公司Laboratory Corporation of America Holdings (Labcorp)宣布推出專為進行性或轉移性固體癌患者量身定做的新型液態切片測試Labcorp Plasma。該測試透過標準抽血評估從癌細胞中提取的循環遊離 DNA (cfDNA)，具有微創性，可快速提供結果。此檢驗可辨識多種常見癌症的臨床可操作生物標記物，包括非小細胞肺癌、大腸直腸癌、乳癌、食道癌、胃食道交界處癌、胃癌和黑色素瘤。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球遊離 DNA (cfDNA) 檢測市場促進因素和阻礙因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球遊離 DNA (cfDNA) 檢測市場規模、表現與成長
  • 全球遊離 DNA (cfDNA) 檢測市場規模與成長預測，2023-2028、2033F

第6章 市場細分

  • 全球遊離 DNA (cfDNA) 測試市場：按產品分類的績效和預測，2018-2023、2023-2028F、2033F
  • 來自捐贈者的遊離 DNA
  • 循環無細胞腫瘤DNA
  • 胎兒遊離DNA
  • 全球遊離 DNA (cfDNA) 測試市場：按平台分類的績效和預測，2018-2023、2023-2028F、2033F
  • 次世代定序（NGS）
  • rPCR 和多重 PCR
  • qPCR 和 dPCR
  • 其他平台
  • 全球遊離 DNA (cfDNA) 測試市場：按應用分類的表現和預測，2018-2023、2023-2028F、2033F
  • 腫瘤學
  • 非侵入性產前檢測（NIPT）
  • 婦科
  • 移植
  • 其他用途

第 7 章 區域/國家分析

  • 全球遊離 DNA (cfDNA) 測試市場，按地區、績效和預測，2018-2023、2023-2028F、2033F
  • 全球遊離 DNA (cfDNA) 測試市場，按國家、績效和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 遊離DNA（cfDNA）檢測市場的競爭格局
  • 無細胞 DNA (cfDNA) 測試市場公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Agilent Technologies Inc.

第31章 其他重大及創新企業

  • Illumina Inc.
  • Qiagen NV
  • Exact Sciences Corporation
  • Bio-Techne Corporation
  • Natera Inc.
  • Myriad Genetics Inc.
  • NeoGenomics Laboratories Inc.
  • Invitae Corporation
  • Foundation Medicine Inc.
  • Guardant Health Inc.
  • Integrated DNA Technologies Inc.
  • Caris Life Sciences Inc.
  • Twist Bioscience Corporation
  • Adaptive Biotechnologies Corporation
  • Biodesix Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18308

Cell-free DNA (cfDNA) testing is a non-invasive diagnostic technique that examines DNA fragments freely circulating in the bloodstream. This testing method is integral to liquid biopsy procedures, enabling the detection and analysis of genetic mutations and alterations without resorting to traditional tissue biopsies.

The primary products within the cell-free DNA (cfDNA) testing market include donor-derived cell-free DNA, circulating cell-free tumor DNA, and cell-free fetal DNA. Donor-derived cell-free DNA originates from transplanted donor organs or tissues and can be found in the recipient's bloodstream. Various platforms are utilized for cfDNA testing, such as next-generation sequencing (NGS), real-time PCR (rPCR) and multiplex PCR, quantitative PCR (qPCR) and digital PCR (dPCR), among others. These platforms are applied across various domains including oncology, non-invasive prenatal testing (NIPT), gynecology, transplantation, and other medical conditions.

The cell-free DNA (cfDNA) testing market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) testing market statistics, including cell-free DNA (cfDNA) testing industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) testing market share, detailed cell-free DNA (cfDNA) testing market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) testing industry. This cell-free DNA (cfDNA) testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell free DNA (cfDNA) testing market size has grown exponentially in recent years. It will grow from $7.07 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth during the historic period can be attributed to several factors, including the increased adoption of cfDNA testing in prenatal care, a growing utilization of cfDNA analysis, heightened interest in cfDNA research across various medical fields, and an increase in gaining approvals from regulatory bodies.

The cell free DNA (cfDNA) testing market size is expected to see exponential growth in the next few years. It will grow to $20.63 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. In the forecast period, growth can be attributed to a shift towards personalized medicine, improvements in healthcare infrastructure, an aging population, and the increasing incidence of cancer. Additionally, the increasing adoption of precision medicine, growing awareness and acceptance of liquid biopsy techniques, and rising investment and funding in cfDNA research are contributing to this growth. Major trends during this period include the adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and the implementation of cloud-based platforms for data storage and analysis.

The increasing prevalence of cancer is expected to drive the growth of the cell-free DNA (cfDNA) testing market in the future. Cancer encompasses a complex group of diseases characterized by abnormal cell growth and spread in the body. These cells can invade and damage normal tissue, posing significant risks if left unchecked. The rise in cancer prevalence is attributed to factors such as aging populations, lifestyle changes, environmental influences, and advancements in detection and diagnostic methods. cfDNA testing detects genetic mutations linked to cancer at early stages, often before symptoms manifest. This early detection enables timely interventions, enhancing patient outcomes and survival rates by identifying cancer in its initial phases. For example, in February 2024, the World Health Organization (WHO) projected over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Hence, the increasing prevalence of cancer is fueling the growth of the cell-free DNA (cfDNA) testing market.

Key players in the cell-free DNA (cfDNA) testing market prioritize the development of innovative technologies, such as liquid biopsy tests that offer heightened sensitivity, specificity, and efficiency in detecting cancer-related mutations and genetic changes. Liquid biopsy tests involve diagnostic procedures enabling oncologists to assess circulating cell-free DNA released by tumor cells, facilitating personalized and targeted therapy strategies. For instance, in May 2023, Laboratory Corporation of America Holdings (Labcorp), a US-based life sciences company, introduced Labcorp Plasma Focus, a new liquid biopsy test tailored for patients with advanced or metastatic solid tumors. This test evaluates circulating cell-free DNA (cfDNA) from tumor cells through a standard blood draw, ensuring minimal invasiveness and rapid results. It enhances access to precision oncology by identifying clinically actionable biomarkers across various common cancers such as non-small cell lung, colorectal, breast, esophageal, gastroesophageal junction, gastric cancers, and melanoma.

In February 2022, Laboratory Corporation of America Holdings (LabCorp), a US-based clinical healthcare company, acquired Personal Genome Diagnostics Inc. for an undisclosed sum. This acquisition positions LabCorp to advance its existing liquid biopsy capabilities and broaden its array of state-of-the-art next-generation sequencing (NGS)-based genomic profiling tools for cancer, positioning it at the forefront of improving patient outcomes. Personal Genome Diagnostics Inc. specializes in precision oncology diagnostics, including cell-free DNA testing technology.

Major companies operating in the cell free DNA (CFDNA) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC

North America was the largest region in the cell-free DNA (CFDNA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell free DNA (CFDNA)) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell free DNA (CFDNA) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) testing market consists of revenue entities earned by providing services such as liquid biopsy for cancer detection and monitoring, transplant rejection monitoring, and non-invasive prenatal testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) testing market also includes sales of products such as digital PCR systems, automated nucleic acid extraction systems, real-time PCR instruments, and library preparation systems for NGS. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Free DNA (cfDNA) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell free dna (cfdna) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell free dna (cfdna) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell free dna (cfdna) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Donor-Derived Cell-Free DNA; Circulating Cell-Free Tumor DNA; Cell-Free Fetal DNA
  • 2) By Platforms: Next Generation Sequencing (NGS); rPCR And Multiplexed PCR; qPCR And dPCR; Other platforms
  • 3) By Application: Oncology; Non-Invasive Prenatal Test (NIPT); Gynecology; Transplantation; Other Applications
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell-Free DNA (cfDNA) Testing Market Characteristics

3. Cell-Free DNA (cfDNA) Testing Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell-Free DNA (cfDNA) Testing Market Size and Growth

  • 5.1. Global Cell-Free DNA (cfDNA) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell-Free DNA (cfDNA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell-Free DNA (cfDNA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell-Free DNA (cfDNA) Testing Market Segmentation

  • 6.1. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Donor-Derived Cell-Free DNA
  • Circulating Cell-Free Tumor DNA
  • Cell-Free Fetal DNA
  • 6.2. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next Generation Sequencing (NGS)
  • rPCR And Multiplexed PCR
  • qPCR And dPCR
  • Other platforms
  • 6.3. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Non-Invasive Prenatal Test (NIPT)
  • Gynecology
  • Transplantation
  • Other Applications

7. Cell-Free DNA (cfDNA) Testing Market Regional And Country Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell-Free DNA (cfDNA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market

  • 8.1. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell-Free DNA (cfDNA) Testing Market

  • 9.1. China Cell-Free DNA (cfDNA) Testing Market Overview
  • 9.2. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell-Free DNA (cfDNA) Testing Market

  • 10.1. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Testing Market

  • 11.1. Japan Cell-Free DNA (cfDNA) Testing Market Overview
  • 11.2. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Testing Market

  • 12.1. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Testing Market

  • 13.1. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Testing Market

  • 14.1. South Korea Cell-Free DNA (cfDNA) Testing Market Overview
  • 14.2. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Testing Market

  • 15.1. Western Europe Cell-Free DNA (cfDNA) Testing Market Overview
  • 15.2. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell-Free DNA (cfDNA) Testing Market

  • 16.1. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Testing Market

  • 17.1. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell-Free DNA (cfDNA) Testing Market

  • 18.1. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Testing Market

  • 19.1. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Testing Market

  • 20.1. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Testing Market

  • 21.1. Eastern Europe Cell-Free DNA (cfDNA) Testing Market Overview
  • 21.2. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Testing Market

  • 22.1. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell-Free DNA (cfDNA) Testing Market

  • 23.1. North America Cell-Free DNA (cfDNA) Testing Market Overview
  • 23.2. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell-Free DNA (cfDNA) Testing Market

  • 24.1. USA Cell-Free DNA (cfDNA) Testing Market Overview
  • 24.2. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Testing Market

  • 25.1. Canada Cell-Free DNA (cfDNA) Testing Market Overview
  • 25.2. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell-Free DNA (cfDNA) Testing Market

  • 26.1. South America Cell-Free DNA (cfDNA) Testing Market Overview
  • 26.2. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Testing Market

  • 27.1. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Testing Market

  • 28.1. Middle East Cell-Free DNA (cfDNA) Testing Market Overview
  • 28.2. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Testing Market

  • 29.1. Africa Cell-Free DNA (cfDNA) Testing Market Overview
  • 29.2. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape
  • 30.2. Cell-Free DNA (cfDNA) Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Laboratory Corporation of America Holdings
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Quest Diagnostics Incorporated
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell-Free DNA (cfDNA) Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Qiagen N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. Bio-Techne Corporation
  • 31.5. Natera Inc.
  • 31.6. Myriad Genetics Inc.
  • 31.7. NeoGenomics Laboratories Inc.
  • 31.8. Invitae Corporation
  • 31.9. Foundation Medicine Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. Integrated DNA Technologies Inc.
  • 31.12. Caris Life Sciences Inc.
  • 31.13. Twist Bioscience Corporation
  • 31.14. Adaptive Biotechnologies Corporation
  • 31.15. Biodesix Inc.

32. Global Cell-Free DNA (cfDNA) Testing Market Competitive Benchmarking

33. Global Cell-Free DNA (cfDNA) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Testing Market

35. Cell-Free DNA (cfDNA) Testing Market Future Outlook and Potential Analysis

  • 35.1 Cell-Free DNA (cfDNA) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell-Free DNA (cfDNA) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell-Free DNA (cfDNA) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer